Nama: chatrunni, angen Ni: Porss9o19042 > Fear: 26 _ aa : Porat + Farmarooar 5 5 5 - Dosen pengampr : Nadroh br site, M5} : ar . Tuhich of the Fouowing druge canbe: odwininjered "HY Sibcotaneoas route 7” ae ) Aburerot wae be Terbutattne: os meee {) Metaproterenot - wr (0) Pirburerot a Mechantim of actian oF theophytine tm bronchiay “asthing DRY phuthedietterace 4 tnbieitfon cai pasar) LR) Bera 2 agonirm . u 0) pnwicbptinergrc_acizon aime ke aa (0) Iwhibieton OF mucceniary clearance ae 3) | vw prevent exercire Meuced bronchiat arthma drug ured iP JENS Sed Cromogiycate ae on _ (8) Aprotropiur bromide 8 - CC) yerburattne - - 0) Eefnephrine oe ES = MY) | which oFabe Fonnwing chugs har been pound-tp be UFEAAI IN aaUe vere asthea To ae | PXCmagnetions sutphate re (8) Anti -\euyorrme ee . (2) ctomoiy sodium (0) cyclosporine me a - a) ae eon CO Cromotyn sodium (9) _Aminsphyttine Dipindai dengan CamScanner|| gai thosrbearer Crerare - which En ye 1s Inhibtied bs aminephytfine (P) eytocrome £ Yr0 . _ ualh which Op the Fltening receptors theophytine har anvertageninetc IMeraction 7 (n) Histamine recertors (6) Bradykemin receptors —_ De Menesine recertors 2 (9) Lridazottee receptors: © An of the FONUUAINS storerenks abOU Aeaphytime are Cerrece’ ExcepE Dinecare io dare HF quid 9 earalepuimonany twas (8) rncteases cAMP fe) wnereasey th dose te requited WW smorers () whwits Phesphodiesterare The (wading dise of aminaphytting Sp ee oan an = Ca) $0 - 95 o/s ree ges) Soa @) os-1 my/ey ©) 22.5 my/% | DES m9 /9 which oF the Fouting [S-netan adverse “erfect: of calbutame: 2-20 re CA) tachycardia (8) qorerance ) voperaiemia, ae a DU vyratt¥emiag at Inhibition oF 5 Upextgenasce 1 Uepar tg et . . _ O) Cardiae foture : a QR Pronebrat arthma (2) Hteyaye fatture 0D) prebriir Dipindai dengan CamScanner(D) Rydrocortigone 1s) | Trriamatien tn the array ean be “reduced by», et eae: DR Frutteasere — oa — WO) Budesonide: 7 5 ()_ ahephuttine OD) Saibutamol Ae cae mee &) tratrertun 1) | true about eopinrart TF + 3 (a) We INKS Mipoocygenase pathuay = (B)_ WW decreases the Frequency oF arthma AHACR as Ompared te siucocortcoide- BY Ve bloces UP receptor ae OP) tek BFFective tn acute bronchtay asthma, CE) We Cancbe adminiteredvormmy set - - a IS)] rags whtch Increare lever of theaphyning (neue ; opt DRY Ciro povarin ne (8) Barbruroter (0 crymetictine ©) Ruopuriors (_Phengtom ao _10)| the fanny drug je not Urepcr during acute attace oF bronchial arthima + CN) Satburareat ©) Hydrocortisone | BT encoyn feduer OD) Theephynine AW oF the Fouweang ckrugs urput tn bronchiay afthme are branch dnaters erpect n) Theerky ine —~...| (8 saimeteros PRY Gectemetharene €®) Ipratropium Dipindai dengan CamScanner_Q) Tremor (8) pairetation PL aryrore nition (0) Huperatemta 19] 2) whith of the Follouing iF @ bronchodnater 7 Pe La) Corticosteroids Sarmeteroi (Ce) Fetotifen (0) Sodtum Cromosiycate The drugs that dues hot peut in theophytine doxrelty tr: Ch) CiproFtoxacin | DRE praoxretum _ Ce) Erythromycin | Uo) cimetidine PUL OF the Folvming IMO can precipitate acute attack “OF asthma: except | Ca) Phenytbutarene (EY Naproxen | De Biucocor-Ncords Pepin Tprerroptue bromide ured in brenchiat arthma ie: (ay _& - surparhomimercs (@)_methyixanghiner DY mmarchotinersiés et (1) mak cen siabatrerr Which of 4he Fenowing s tong acting symphatomimene UP) Satbutaror — (6) Yerburanine Cc) Bambureror pStemarm uy ea In bronchiay arth Dipindai dengan CamScannerNara : chatruantra Rangeut Nim + PO7639019042. Kets 2 2¢ bara: Farmakowoai 7 Doser Fengarmru: Nadroh br sttepy, mS %)|_pextbromerthophan is an + (a) Antihirtomine DRL prtinassive (0) Expectorant, (0) AnWauersie 25)|_Drndium cromogiveate ir ured by uhtch oF OR Inhatetion (Ce) ora tc) w ow) 1m F the Foltwuing routes 2 3) whith IF a “soft Steroid" ase in bronchiz arthma 7 Ch) Budesonide | (B)_Peranerbarene BY cictesontde () plantsarrde PD] omattqueab if adeinirtered an bronchial arthen by Which route 2 OB) ort (8)_{htravensur PY Subcuyane our WW) Perso. 28) Drreckty acting cough Suppressant ir: PY Pexthomorhirphan a (8) Brochexine Ce) Aeeys Cysteine (0) Corbapentate Dipindai dengan CamScannerwn 4 patent oF chronfe arth on treatment with theophylline Shourel (A)_Amrictitin (8) Cephatexin BY eytheeyen @ AW not be ured to treat her uprer respiratory trace inre ction 7 rwdich oF the Fousumny 30), aD 53) | aren eereeenes galas which of the FelllMing INhBAS Atrephytiine merbottsm 7 (a) 1H _— (8) Grireofutvin Le)__prentdsorone DR ciertxacim Langest acting B~ agonirt 1m + (A) Satbutamet “@) Taburatine BY wimeterh (0) Theophytitne fds stro inewde + DR ora candiciouir (8) chusing'F syndrome (6) Peereaved petH () _Systernic compiteaaiont The frilmuiny dniy is contramacared In bronchial asthma y A) Prepanaiei (8) Upratropnum Sromicle . BY Theephyutne 0) Ketotigen Dipindai dengan CamScannerge) | Aavantese_ oF sowmerero\ over salbutama\ tr ts. ~~] cn) shorter duration oF action = (g) more PpoTency Pe Corger_duraton °F acho (9) Lesser Cardiac effects $h)| inveraction oF theophytiine with cleropiowach, IS { tee © aa ee eis CA) COPMFLOXACIN WWereaser theophylline Metabottem Dou ace OS. Cipre plexacin dlecreares abeophyittne metokovirm, . (ec) Theophyttine fRereacer cipropiexocen rmetateeitrm eee (0) yheaphytiine decrearer ciprofloxacin merabsitrm a ae “s)| theaphyvine overdose cousers' = = th) Brady carci ee ae BE scrrures es (©) Prowsiness Sa (p) Brochorparm 38)|-phera peutic bieod range of theophyume tn-mtersoraim per rviitters: br (rn) “0-5 eae (8) S10 = : bY s- Rea aS OYs- 2 . nwt WW theophyltine metabniirm 7 Ang Teremctors Occurs with al) exeépt Ca) Crmernatine (8) Phensharbitone Ce) Rigompine pases 48) | Mechanipm OF Acton oF theuphytiine tm bronchioy ostina include aut ofthe fonrutrig “Oxcert 2_| DT phesphediesterase inbivition Es . * —__| @) Adenosine receptor antagoniry om oy locreared, lhirtene deacetylation aS : : —|_ 9) Bema — 2 receptor shmuiation Dipindai dengan CamScanner{8) orexprenaiine Cc) penoterel a ()__ rex borer) Eppreacy of cammeteror int inereased IF It I oven ateng with + UK) Theophytne DIC corticostersic ©) Ipratroptim () sodrim —crpmegiyeate — 435) Ormalitumab IC indteateel Fer which oF the Fonwwing enditions: ¢ CR) Mutivie myctoma CB) Peron DY Bronchiay arthma | (>) Pheumatod arthrie at) Most commen dese felated'iside errects oF Salbutamer Jf s ~ “.. 8 ta) Nervous ness DY paiitation 5 CC) Festiessness (D) Tremors whith of the Fonvams (a long aching bern 2 agenint “Qo th) Salbutamey DET sor metersy (Cc) Terburatine ©) Levaibuteroy : fer Competitive antagonint— op (eurstriene teceptors: See ee aR RSE Y OF Actin OF “monteucart Js) Pee | (8) wwhteits atthe receptor LCC) Bera receptor agonire : am 40) on ~ competitive (nhieu = Dipindai dengan CamScannerchatnannise Pangrutt 26 Dut 453O0190N2, ~aa)| mechanic oF actin “op aecton IF 7 = _.. ~__[ a) wher production of Ige DPS rwnibits lipoxyoenase Co) Anhieits Cycloxygen« ce Ss ar a () Anhibrrs activity OF mark cene . a ~MB)] whith oF the fawvkins deer nat have a role in acute attack oF arthma 2 - | DY cromotyn‘sodtim : < z (8) Spratropiuns eek _ Z (c) Steroids = = (©) Fatburamoy : Tae eae ~49)} which OF the Folttuing IF net eS eaaias 2 i (A) Betas 2 qgonirt ass a are () methylxanthines i PY Sere — ©) Anti chotinergics a 5 50)| Orug oF chore for treatment oF acute aithmate attacks ir + CA) Leukstrine aMtagenists ic. 6 a | Lipoxygenase whiertors PX beta 2. asoniet () pnt cbolinernies — ) |vhich oF the Fouvuims clart drug 1s a preapitant opacute asthma BI tA) Beta =adrenersre receptor agonirt - PE ysrips Co) Caltium channe, borers @) Wy bieckers Adverse erpects of calmetero) anclude s (A) Hyrerteatemia, (ey Seraures 7 : Dipindai dengan CamScanner——————————— 25) =) )|which oF the Felloams fra tons denny Gr selective agonint 7 a nth (A3M Yeore - ard man With & Leng hirteny of areal rs tererred YO Pulmanclogiey qhe physittan decides to preserthe geuton The mechaniem OF action © thie. S9) fede, Day Aremgenine LeUroInne PH receptor (BD inkibir O- Mpexugenase Ce) \nhionts PhoiPhodverteraser (0) stimurate beta 2 Peceptors ‘Select the Correct oretrment Mrgarding Ure oF Inhaled tucocort corde rin bomchter asthe ta) They are ured Por acute attacts oF arthmn (8) They have hish systemic athvity Ce) They are Surertor to Bi agonirts In symptom centro! Tee ae PY ory Candelasts Can occur as a side erfect ae Which of the fetiouns Anus tr not used Inet urdd In the treatinard of brondhial arthma! @) Ar ageniet — t 1) Contrca trevor (PRC Chotwerterase jakibtrore (0) phas phadtesterase tnkfeiters AN the Feltming are user) tn the management ef acute atthma® sxeert CA) He arecortisone intravenously “ @) Sarburamer inhalation PY Smeteroy ynhoration () Terbutaring whalation Which oF the Faivuing drugs preents the reteare OF leutberreney anal hirtamme fears trast cus 2 oa (A) Meaten () FexoFenodine BE vedoeromn D) Torrptun DR Formeterar —— a CO) soutattarat ee oy “ephedrine aes Dipindai dengan CamScannerio bronchial asta the rnechor ire OF @CHON OF Cortrcosterotds 15 7 Ton) Relax airways Smooth rurcle aditectg rte) InBits mart cell dereguiation Gey WT adenosine receptors Se nM WyrnpheewETe GesmEPhIC MUETA) InFlammavion Leukortiones Inhibitors are very erfechve (ny ubich one of the pouvwing Conditions : Day cxereive induced atthma (8) Antigen induced Atthma Tc) Aspmin Induced asthma @® occupational arthma any inated sodium cromogtycate + LA) Prevents the antven antibody combmation (8) May caule Cardiac arrbythmiat PS TOF benenit In Preventing exercire induced bronchial Spar WS IS FFE CVE IN alleviating an acute epitedé of allergrc arthwna 6) most Corman side efpect oF inhalational become --tharone UM : OR) Rarerar Suppression t8) oropharyngeal cand«diasir LF Bronchocontriction Lo) Reparttir SfFicacy oF inkaied Seeroids im maximuny when Parerelé sfte IF: | Dy -s Ye (8) oto Ye Ce) ONS Ben, _|_ © Re Whihtors OD) IF -20 He GY] heaton ie + DS S \gooxgomase wribner LO) Leustrine receptor antagonist Dipindai dengan CamScanner